Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma
Juan Pablo Alderuccio(Sylvester Comprehensive Cancer Center), Izidore S. Lossos(University of Miami), Sara Haddadi(University of Miami), Thomas M. Habermann(Mayo Clinic in Arizona), Jonathan W. Friedberg(University of Rochester), Peter Martin(Northwestern University), Dai Chihara(The University of Texas MD Anderson Cancer Center), Isildinha M. Reis(University of Miami), Brad S. Kahl(UW Health University Hospital), James R. Cerhan(Mayo Clinic), Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), Jean L. Koff(Emory University), Jennifer R. Chapman(University of Miami), Wei Zhao(University of Miami), Christopher Strouse(University of Iowa Hospitals and Clinics), Melissa C. Larson(Mayo Clinic), Jonathon B. Cohen(Emory University)
Cited by 14
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k